1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Asthma, Bronchial in 3 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, T | 1 |
| Luo, G | 1 |
| Zhang, Y | 1 |
| Wang, X | 2 |
| Wu, M | 1 |
| Li, G | 1 |
| LoGrasso, PV | 1 |
| Feng, Y | 1 |
| Doelman, CJ | 1 |
| Borm, PJ | 1 |
| Bast, A | 1 |
1 review available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Asthma, Bronchial
| Article | Year |
|---|---|
Rho kinase (ROCK) inhibitors and their application to inflammatory disorders.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anti-Inflammatory Agents; Asthma; Humans; In | 2009 |
2 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Asthma, Bronchial
| Article | Year |
|---|---|
Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Allergens; Animals; Asthma; Case-Control Studies; Cel | 2015 |
Plasticisers, another burden for asthmatics?
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Asthma; Diethylhexyl Phthalate; Dose-Respons | 1990 |